Blog

Call to Action on the implementation of Joint Clinical Assessment for ATMPs

Photo from CPE/LinkedIn

Jul 11, 2024, 15:38

Call to Action on the implementation of Joint Clinical Assessment for ATMPs

Cancer Patients Europe (CPE) shared on LinkedIn:

“CPE, in collaboration with the Alliance for Regenerative Medicine and Fondazione Telethon, has launched a Call to Action on the implementation of the EU Joint Clinical Assessment (JCAs) for Advanced Therapy Medicinal Products (ATMPs).

With the support of more than 30 signatories, we are urging the HTA Coordination Group and JCA assessors to ensure that JCA methodologies do not hinder Patient Access and the innovation of ATMPs in Europe.

Read the press release.”

Source: CPE/LinkedIn

Alliance for Regenerative Medicine ATMPs cancer Cancer Patients Europe CPE Fondazione Telethon HTA Coordination Group JCA Joint Clinical Assessment OncoDaily Oncology

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage